Indications and Limitations of Afamelanotide for Treating Vitiligo—Reply

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	JAMA dermatology (Chicago, Ill.) Ill.), 2015-03, Vol.151 (3), p.350-350
Hauptverfasser:	Lim, Henry W, Grimes, Pearl E, Lebwohl, Mark
Format:	Artikel
Sprache:	eng
Schlagworte:	alpha-MSH - analogs & derivatives Female Humans Male Ultraviolet Therapy - methods Vitiligo - therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page	350
container_issue	3
container_start_page	350
container_title	JAMA dermatology (Chicago, Ill.)
container_volume	151
creator	Lim, Henry W Grimes, Pearl E Lebwohl, Mark
description
doi_str_mv	10.1001/jamadermatol.2014.4951
format	Article
fullrecord	<record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1663658698</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><ama_id>2091533</ama_id><sourcerecordid>1663658698</sourcerecordid><originalsourceid>FETCH-LOGICAL-a330t-f9c06ca85884815862e04f256a0c552d03740e18816999d5d77f000ed9b995243</originalsourceid><addsrcrecordid>eNpNkMtOAjEUhhujEYK8gAsySzeDp9ML7ZIQLxgSE4NumzJtScnMFKfDgp0P4RP6JJaAl7Ppac7_n_PnQ2iEYYwB8O1G19rYttZdqMYFYDqmkuEz1C8wFzkHQc9_ey56aBjjBlIJAErwJeoVjMNEFKKPnuaN8aXufGhiphuTLXztu9M_uGzqdG0r3YTOG5u50GbL1qZxs87efOcrvw5fH58vdlvtr9CF01W0w9M7QK_3d8vZY754fpjPpotcEwJd7mQJvNSCCUEFZoIXFqhLiTSUjBUGyISCxUJgLqU0zEwmLmW3Rq6kZAUlA3Rz3Lttw_vOxk7VPpa2Silt2EWFOSc87ZUiSflRWrYhxtY6tW19rdu9wqAOKNV_lOqAUh1QJuPodGO3qq35tf2AS4LroyD5_6YgMSOEfAMxqnsO</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1663658698</pqid></control><display><type>article</type><title>Indications and Limitations of Afamelanotide for Treating Vitiligo—Reply</title><source>MEDLINE</source><source>American Medical Association Journals</source><creator>Lim, Henry W ; Grimes, Pearl E ; Lebwohl, Mark</creator><creatorcontrib>Lim, Henry W ; Grimes, Pearl E ; Lebwohl, Mark</creatorcontrib><identifier>ISSN: 2168-6068</identifier><identifier>EISSN: 2168-6084</identifier><identifier>DOI: 10.1001/jamadermatol.2014.4951</identifier><identifier>PMID: 25607828</identifier><language>eng</language><publisher>United States: American Medical Association</publisher><subject>alpha-MSH - analogs & derivatives ; Female ; Humans ; Male ; Ultraviolet Therapy - methods ; Vitiligo - therapy</subject><ispartof>JAMA dermatology (Chicago, Ill.), 2015-03, Vol.151 (3), p.350-350</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a330t-f9c06ca85884815862e04f256a0c552d03740e18816999d5d77f000ed9b995243</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://jamanetwork.com/journals/jamadermatology/articlepdf/10.1001/jamadermatol.2014.4951$$EPDF$$P50$$Gama$$H</linktopdf><linktohtml>$$Uhttps://jamanetwork.com/journals/jamadermatology/fullarticle/10.1001/jamadermatol.2014.4951$$EHTML$$P50$$Gama$$H</linktohtml><link.rule.ids>64,314,780,784,3339,27923,27924,76260,76263</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25607828$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lim, Henry W</creatorcontrib><creatorcontrib>Grimes, Pearl E</creatorcontrib><creatorcontrib>Lebwohl, Mark</creatorcontrib><title>Indications and Limitations of Afamelanotide for Treating Vitiligo—Reply</title><title>JAMA dermatology (Chicago, Ill.)</title><addtitle>JAMA Dermatol</addtitle><subject>alpha-MSH - analogs & derivatives</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Ultraviolet Therapy - methods</subject><subject>Vitiligo - therapy</subject><issn>2168-6068</issn><issn>2168-6084</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpNkMtOAjEUhhujEYK8gAsySzeDp9ML7ZIQLxgSE4NumzJtScnMFKfDgp0P4RP6JJaAl7Ppac7_n_PnQ2iEYYwB8O1G19rYttZdqMYFYDqmkuEz1C8wFzkHQc9_ey56aBjjBlIJAErwJeoVjMNEFKKPnuaN8aXufGhiphuTLXztu9M_uGzqdG0r3YTOG5u50GbL1qZxs87efOcrvw5fH58vdlvtr9CF01W0w9M7QK_3d8vZY754fpjPpotcEwJd7mQJvNSCCUEFZoIXFqhLiTSUjBUGyISCxUJgLqU0zEwmLmW3Rq6kZAUlA3Rz3Lttw_vOxk7VPpa2Silt2EWFOSc87ZUiSflRWrYhxtY6tW19rdu9wqAOKNV_lOqAUh1QJuPodGO3qq35tf2AS4LroyD5_6YgMSOEfAMxqnsO</recordid><startdate>20150301</startdate><enddate>20150301</enddate><creator>Lim, Henry W</creator><creator>Grimes, Pearl E</creator><creator>Lebwohl, Mark</creator><general>American Medical Association</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20150301</creationdate><title>Indications and Limitations of Afamelanotide for Treating Vitiligo—Reply</title><author>Lim, Henry W ; Grimes, Pearl E ; Lebwohl, Mark</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a330t-f9c06ca85884815862e04f256a0c552d03740e18816999d5d77f000ed9b995243</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>alpha-MSH - analogs & derivatives</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Ultraviolet Therapy - methods</topic><topic>Vitiligo - therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lim, Henry W</creatorcontrib><creatorcontrib>Grimes, Pearl E</creatorcontrib><creatorcontrib>Lebwohl, Mark</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>JAMA dermatology (Chicago, Ill.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lim, Henry W</au><au>Grimes, Pearl E</au><au>Lebwohl, Mark</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Indications and Limitations of Afamelanotide for Treating Vitiligo—Reply</atitle><jtitle>JAMA dermatology (Chicago, Ill.)</jtitle><addtitle>JAMA Dermatol</addtitle><date>2015-03-01</date><risdate>2015</risdate><volume>151</volume><issue>3</issue><spage>350</spage><epage>350</epage><pages>350-350</pages><issn>2168-6068</issn><eissn>2168-6084</eissn><cop>United States</cop><pub>American Medical Association</pub><pmid>25607828</pmid><doi>10.1001/jamadermatol.2014.4951</doi><tpages>1</tpages></addata></record>
fulltext	fulltext
identifier	ISSN: 2168-6068
ispartof	JAMA dermatology (Chicago, Ill.), 2015-03, Vol.151 (3), p.350-350
issn	2168-6068 2168-6084
language	eng
recordid	cdi_proquest_miscellaneous_1663658698
source	MEDLINE; American Medical Association Journals
subjects	alpha-MSH - analogs & derivatives Female Humans Male Ultraviolet Therapy - methods Vitiligo - therapy
title	Indications and Limitations of Afamelanotide for Treating Vitiligo—Reply
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T09%3A58%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Indications%20and%20Limitations%20of%20Afamelanotide%20for%20Treating%20Vitiligo%E2%80%94Reply&rft.jtitle=JAMA%20dermatology%20(Chicago,%20Ill.)&rft.au=Lim,%20Henry%20W&rft.date=2015-03-01&rft.volume=151&rft.issue=3&rft.spage=350&rft.epage=350&rft.pages=350-350&rft.issn=2168-6068&rft.eissn=2168-6084&rft_id=info:doi/10.1001/jamadermatol.2014.4951&rft_dat=%3Cproquest_cross%3E1663658698%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1663658698&rft_id=info:pmid/25607828&rft_ama_id=2091533&rfr_iscdi=true